MA51297A - QUINAZOLINONES AS PARP14 INHIBITORS - Google Patents

QUINAZOLINONES AS PARP14 INHIBITORS

Info

Publication number
MA51297A
MA51297A MA051297A MA51297A MA51297A MA 51297 A MA51297 A MA 51297A MA 051297 A MA051297 A MA 051297A MA 51297 A MA51297 A MA 51297A MA 51297 A MA51297 A MA 51297A
Authority
MA
Morocco
Prior art keywords
quinazolinones
parp14
inhibitors
parp14 inhibitors
Prior art date
Application number
MA051297A
Other languages
French (fr)
Other versions
MA51297B1 (en
Inventor
Kevin Wayne Kuntz
Laurie B Schenkel
Kerren Kalai Swinger
Melissa Marie Vasbinder
Original Assignee
Ribon Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribon Therapeutics Inc filed Critical Ribon Therapeutics Inc
Priority claimed from PCT/US2018/066700 external-priority patent/WO2019126443A1/en
Publication of MA51297A publication Critical patent/MA51297A/en
Publication of MA51297B1 publication Critical patent/MA51297B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA51297A 2017-12-21 2018-12-20 Quinazolinones as parp14 inhibitors MA51297B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762608747P 2017-12-21 2017-12-21
PCT/US2018/066700 WO2019126443A1 (en) 2017-12-21 2018-12-20 Quinazolinones as parp14 inhibitors

Publications (2)

Publication Number Publication Date
MA51297A true MA51297A (en) 2020-10-28
MA51297B1 MA51297B1 (en) 2023-01-31

Family

ID=71842911

Family Applications (1)

Application Number Title Priority Date Filing Date
MA51297A MA51297B1 (en) 2017-12-21 2018-12-20 Quinazolinones as parp14 inhibitors

Country Status (2)

Country Link
AR (1) AR114003A1 (en)
MA (1) MA51297B1 (en)

Also Published As

Publication number Publication date
AR114003A1 (en) 2020-07-08
MA51297B1 (en) 2023-01-31

Similar Documents

Publication Publication Date Title
MA49903A (en) SULPHONYLURIDES AND SULPHONYLTHIOURIDES AS NLRP3 INHIBITORS
MA48994A (en) ISOQUINOLEINS USED AS HPK1 INHIBITORS
MA52486A (en) PYRIDAZINONES USED AS PARP7 INHIBITORS
MA47460A (en) AMINOTRIAZOLOPYRIDINES USED AS KINASE INHIBITORS
MA45244A (en) SUBSTITUTED PYRIDINES USED AS DNMT1 INHIBITORS
MA47013A (en) BENZOLACTAM COMPOUNDS USED AS KINASE PROTEIN INHIBITORS
MA41551A (en) BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS
DK3497103T3 (en) PYRIDOPYRIMDINONE-CDK2 / 4/6 INHIBITORS
MA44725A (en) LSD1 INHIBITOR FORMULATIONS
MA52413A (en) CD73 INHIBITORS
MA43862A (en) SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS ROCK INHIBITORS
MA52063A (en) N - ((HET) ARYLMETHYL) HETEROARYL-CARBOXAMIDES COMPOUNDS AS PLASMATIC KALLICREIN INHIBITORS
MA43169A (en) HETEROCYCLIC COMPOUNDS USED AS PI3K-GAMMA INHIBITORS
MA40587A (en) AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS
MA40774A (en) DIARYLEUREA DERIVATIVES AS KINASE P38 INHIBITORS
MA46981A (en) BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS
MA42659A (en) HETERARYL DERIVATIVES USED AS PARP INHIBITORS
MA41140A (en) 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS PARG INHIBITORS
MA51232A (en) INDANE-AMINES USEFUL AS PD-L1 ANTAGONISTS
MA54567A (en) PYRIDINE AND PYRIDIMINE COMPOUNDS AS PI3K-GAMMA INHIBITORS
MA46180A (en) ANALOGUES OF AMYLINE
MA52123A (en) 6-PYRIMIDINE-ISOINDOLE DERIVATIVE USED AS AN ERK1 / 2 INHIBITOR
MA41350A (en) SUMMARY OF A BRUTON TYROSINE KINASE INHIBITOR
MA48803A (en) 6-5 MERGED CYCLES USED AS C5A INHIBITORS
MA47736A (en) USEFUL PYRIMIDOPYRIMIDINONES AS KINASE WEE-1 INHIBITORS